Intriguingly, the authors did show that, at least in tumour cells, loss of SMAD4 expression correlated with reduced hydroxymethylation, implicating TGFβ signalling as an additional regulator of hydroxymethylation. This evidence concerns the gene TGFB1 and neoplasm.